These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9732941)

  • 1. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
    Banner BF; Karamitsios N; Smith L; Bonkovsky HL
    Am J Gastroenterol; 1998 Sep; 93(9):1541-5. PubMed ID: 9732941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Computerized histological analysis in chronic viral hepatitis].
    Hassan C; Tavani PD; Serafini B
    Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR; Millward-Sadler GH; Barbatis C; Wright R
    N Engl J Med; 1981 Mar; 304(10):557-60. PubMed ID: 6969850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency.
    Bergwitz C; Brabant G; Trautwein C; Manns MP
    Am J Gastroenterol; 2002 Apr; 97(4):1050-2. PubMed ID: 12003388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterozygosity for alpha1-antitrypsin deficiency as a cofactor in the development of chronic liver disease].
    Kok KF; Wahab PJ; de Vries RA
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2057-61. PubMed ID: 16184948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.
    Kok KF; Wahab PJ; Houwen RH; Drenth JP; de Man RA; van Hoek B; Meijer JW; Willekens FL; de Vries RA
    Neth J Med; 2007 May; 65(5):160-6. PubMed ID: 17519511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects for interferon therapy in chronic hepatitis C with normal transaminase levels].
    Voronkova NV; Blokhina NP; Kelli EI; Mikhaĭlov MI; Malyshev NA
    Ter Arkh; 2002; 74(11):12-5. PubMed ID: 12498116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C treatment without liver biopsy].
    Siboni A
    Ugeskr Laeger; 2002 Mar; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484
    [No Abstract]   [Full Text] [Related]  

  • 13. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
    Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
    Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF; Said AT; Cummings OW; Born LJ
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
    Itoh Y; Okanoue T; Ohnishi N; Sakamoto M; Nishioji K; Nakagawa Y; Minami M; Murakami Y; Kashima K
    Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
    Coverdale SA; Khan MH; Byth K; Lin R; Weltman M; George J; Samarasinghe D; Liddle C; Kench JG; Crewe E; Farrell GC
    Am J Gastroenterol; 2004 Apr; 99(4):636-44. PubMed ID: 15089895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with alpha-interferon in chronic hepatitis.
    Matei I; Tănăsescu C; Voiosu R; Murariu E; Dragomir P; Serbănescu A
    Rom J Intern Med; 1998; 36(3-4):227-37. PubMed ID: 10822519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.